As of 23 of March XTL Biopharmaceutica maintains Downside Deviation of 4.99, Mean Deviation of 3.53 and Risk Adjusted Performance of 0.0402. In relation to Fundamental Indicators, Macroaxis technical analysis interface lets you check available technical drivers of XTL Biopharmaceuticals Ltd as well as the relationship between them. Specifically you can use this information to find out if the organization will indeed mirror its model of past data patterns or the prices will eventually revert. We found nineteen technical drivers for XTL Biopharmaceuticals which can be compared to its rivals. Please check out XTL Biopharmaceuticals Information Ratio, Treynor Ratio, Value At Risk, as well as the relationship between Jensen Alpha and Maximum Drawdown to decide if XTL Biopharmaceuticals is priced some-what accurately providing market reflects its latest price of 9.1 per share.
|Horizon||30 Days Login to change|
XTL Biopharmaceuticals Technical Analysis
We are not able to run technical analysis function on this symbol. We either do not have that equity or its historical data is not available at this time. Please try again later.
XTL Biopharmaceuticals Trend AnalysisUse this graph to draw trend lines for XTL Biopharmaceuticals Ltd. You can use it to identify possible trend reversals for XTL Biopharmaceutica as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual XTL Biopharmaceutica price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.
XTL Biopharmaceutica Best Fit Change LineThe following chart estimates an ordinary least squares regression model for XTL Biopharmaceuticals Ltd applied against its price change over selected period. The best fit line has a slop of 0.06 % which means XTL Biopharmaceuticals Ltd will continue generating value for investors. It has 78 observation points and a regression sum of squares at 38.73, which is the sum of squared deviations for the predicted XTL Biopharmaceutica price change compared to its average price change.
|Risk Adjusted Performance||0.0402|
|Market Risk Adjusted Performance||(0.28)|
|Coefficient Of Variation||2272.16|
|Total Risk Alpha||(0.27)|
|Value At Risk||(7.37)|
|Expected Short fall||(4.33)|